CMS has admitted that it has no hard evidence to back up deputyadministrator Leslie Norwalk's Congressional testimony thatpharmacies are being paid for Part D scripts on a 15-day billingcycle. Instead, Norwalk's assertion was based on informalinformation provided by Part D drug plans.
CMS admits no hard data on pharmacy payments
CMS has admitted that it has no hard evidence to back up deputy administrator Leslie Norwalk's Congressional testimony that pharmacies are being paid for Part D scripts on a 15-day billing cycle. Instead, Norwalk's assertion was based on informal information provided by Part D drug plans. The agency did not ask retail pharmacies about their experiences with slow payments from PBMs administering Part D plans.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Improved Understanding of Hidradenitis Suppurativa Can Enhance Patient Outcomes
July 14th 2025Researchers assessed the difference between hidradenitis suppurativa and other skin conditions regarding the initiating events, inflammatory signature, and molecular and clinical features of each disease.